Abbott's Cologuard Plus® receives CE Mark for colorectal cancer screening in Europe

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Abbott

More Like This

FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer

EDX Medical’s New Advanced Bowel Cancer Testing Service to Launch in UK to Improve Early Detection

Business Wire associated0

Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

Hologic’s Aptima® HPV Assay and Aptima Multitest Specimen Collection Kit

CE-IVDR Mark for Hologic’s Aptima® HPV Test Expanded to Include Self-Collected Sample Claim in Cervical Cancer Screening

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Waiv Achieves Dual CE Marking Under IVDR, Propelling AI Precision Testing for Breast and Colorectal Cancer for Clinical Routine

PR Newswire associated0

Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates

Augere Medical Secures MDR CE-mark for its PolypAId™ Software and System